Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | MAOA | P21397 | 10/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.61 |
| ▸ | CASP1 | P29466 | 1/20 | 0.61 |
| ▸ | CASP7 | P55210 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2521419 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1MAOAGLACYP3A4 | |
| SCHEMBL30947375 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1MAOAGLACYP3A4 | |
| SCHEMBL12914543 | 0.86 | KDM4E (0.75) | KDM4EALDH1A1MAOAGLACYP3A4 | |
| SCHEMBL537382 | 0.84 | KDM4E (0.72) | KDM4EALDH1A1MAOAGLACYP3A4 | |
| SCHEMBL29386410 | 0.84 | KDM4E (0.72) | KDM4EALDH1A1MAOAGLACYP3A4 | |
| SCHEMBL8113673 | 0.80 | KDM4E (0.67) | KDM4EALDH1A1MAOAGLACYP3A4 | |
| SCHEMBL1794300 | 0.80 | ALDH1A1 (0.67) | KDM4EALDH1A1MAOAHPGDSMN1; SMN2 | |
| SCHEMBL8558621 | 0.80 | KDM4E (0.67) | KDM4EALDH1A1MAOACYP3A4MAPT | |
| SCHEMBL2519665 | 0.80 | KDM4E (0.67) | KDM4EALDH1A1MAOAGLACYP3A4 | |
| SCHEMBL8105545 | 0.80 | ALDH1A1 (0.67) | KDM4EALDH1A1MAOAGLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240343738-A1 | Method for preparing pranoprofen and composition comprising pranoprofen and impurity | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2024-10-17 | — | — | US | disclosed |
| EP-4361155-A1 | METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2024-05-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240343738-A1 | Method for preparing pranoprofen and composition comprising pranoprofen and impurity | CYP3A5, CYP3A43, CYP4A11 | KDM4E 3123/4885ALDH1A1 205/4885MAOA 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.